Rare Disease Key Account Director

Pfizer Belgium; Phoenix (AZ); On-site; USD 177,000 - 294,000; Full time

Benefits offered by this job

401(k) matching

Retirement contributions

Vacation & holidays

Personal days

Caregiver/Parental leave

Health benefits

Job summary

Pfizer is seeking a Rare Disease Key Account Director (KAD) to develop market insights and manage strategic relationships with RD stakeholders. You will lead account plans, identify partnership opportunities, and coordinate with cross-functional teams to deliver Pfizer priorities.

The role requires strong account management, leadership across teams, and expertise in Rare Disease or specialty cardiovascular markets. Excellent communication with C-Suite leaders is essential.

Qualifications

• Management/Account Management experience required or strongly recommended.
• Rare Disease and/or Specialty Cardiovascular experience preferred.
• 5-10 years of pharma/biotech marketing/sales with leadership.
• Product launch experience preferred.
• Prior team management preferred.

Responsibilities

• Develop and manage RD KAD accounts and pull-through opportunities.
• Build relationships with C-Suite and RD service line leaders within accounts.
• Lead cross-functional teams to support account plans and Pfizer priorities.
• Identify opportunities for synergy between Pfizer and customer accounts.
• Provide regional insights to inform market strategy and account planning.

Skills

Healthcare market knowledge

Leadership

Account management

Product launch

Cross-functional collaboration

Strategic planning

Education

Bachelor's Degree

MBA or advanced degree

Job description

Pfizer is seeking a Rare Disease Key Account Director (KAD) to develop market insights and manage strategic relationships with RD stakeholders. You will lead account plans, identify partnership opportunities, and coordinate with cross-functional teams to deliver Pfizer priorities.

The role requires strong account management, leadership across teams, and expertise in Rare Disease or specialty cardiovascular markets. Excellent communication with C-Suite leaders is essential.